MacroGenics reported $-33437000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Amgen USD 3.6B 147M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Genmab DKK 376M 172M Jun/2025
Geron USD -7550000 8.85M Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
MacroGenics USD -33437000 17.35M Jun/2025
Merck USD 7.74B 625M Mar/2025
Pfizer USD 5.32B 889M Jun/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Xencor USD -30519000 6.39M Jun/2025